3-orthopedic-software-market

1. Orthopedic Software Market Technological Advancement And Growth Analysis With Forecast 2037 Research Nester assesses the growth and market size of the global orthopedic software market, which is anticipated to be driven by the increasing prevalence of orthopedic disorders and the availability of orthopedic software as cloud-based solutions. Research Nester’s recent market research analysis on ‘Orthopedic Software Market: Global Demand Analysis & Opportunity Outlook 2037” delivers a detailed competitor’s analysis and overview of the global orthopedic software market in terms of market segmentation by product type, delivery mode, application, and end-use. Request for customization @ https://www.researchnester.com/customized-reports-6619 Integrating With Electronic Health Records (EHR) And Other eHealth Technologies The integration of advanced technologies such as AI and IoT eradicates the requirement for manual entry, reducing errors and saving time. With the increase of digital health, orthopedic practice is gradually looking for solutions that can seamlessly connect with hospital EHR systems safeguarding orthopedic precise data that is readily accessible with broader healthcare networks. Similarly, the data integration provides a foundation for improved interoperability across different health IT platforms which is important for achieving efficient coordinated care, mainly for patients with various chronic conditions. For example, In April 2024, Materialise NV launched its Mimics Enlight CMF, a 3D planning software, that provides user-friendly preoperative 3D planning solutions. This product launch is estimated to advance its product portfolio and improve its industry position. Growth Drivers Government initiatives for IT and healthcare • Increase in outpatient and ambulatory surgery centers (ASCs) • Challenges The potential risks of software malfunctions represent a substantial challenge for the orthopedic software market. A malfunction in orthopedic software can lead to improper diagnoses, unsuitable treatment plans, and even surgical mistakes which can compromise patient safety and lead to critical legal consequences for healthcare providers. According to a

2. report by the ECRI Institute, in January 2022, software errors were among the top 10 health technology hazards with about 40% of healthcare providers reporting problems related to software functionality that harmfully impacted patient care. Access our detailed report at: https://www.researchnester.com/reports/orthopedic-software-market/6619 Based on product type, the orthopedic EHR segment is predicted to capture 52.4% of the global market share by 2037 owing to the rising prevalence of various orthopedic disorders and increasing its adoption in clinical settings. This software provides specialized data on patient's orthopedic conditions. The growth is also determined by the advancement in medical imaging technology and the rising demand for precision in surgical outcomes. This report also provides the existing competitive scenario of some of the key players of the global orthopedic software market which includes company profiling of Brainlab AG, Materialise NV, GE Healthcare, Stryker Corporation, Medstrat, Inc. Fujifilm Holdings Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Nihon Kohden Corporation, and Konica Minolta Healthcare. Request Report Sample@ https://www.researchnester.com/sample-request-6619 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives make wise decisions for their future marketing strategy, expansion investment, etc. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds. Our out-of-the-box thinking helps our clients to make wise decisions to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123